REGULATED INFORMATION INSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients First ACCCESS patient expected to be implanted in Q4 2022 Mont-Saint-Guibert, Belgium – July 11, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company […]

Read More

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the “Class Period”), of the important August 5, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read More

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Okta, Inc. (NASDAQ: OKTA) between March 5, 2021 and March 22, 2022, both dates inclusive (the “Class Period”), of the important July 19, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read More

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October 28, 2021 and May 2, 2022, both dates inclusive (the “Class Period”), of the important than July 25, 2022 lead plaintiff deadline. SO WHAT: […]

Read More

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IonQ, Inc. (NYSE: IONQ) between March 30, 2021 and May 2, 2022, both dates inclusive (the “Class Period”), of the important August 1, 2022 lead plaintiff deadline. SO WHAT: If you […]

Read More